Cargando…
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections
BACKGROUND: COVID-19 has proved to be a fatal disease of the year 2020, due to which thousands of people globally have lost their lives, and still, the infection cases are at a high rate. Experimental studies suggested that SARS-CoV-2 interacts with various microorganisms, and this coinfection is ac...
Autores principales: | Ojha, Rupal, Singh, Satyendra, Gupta, Nidhi, Kumar, Ketan, Padhi, Aditya K., Prajapati, Vijay Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163573/ https://www.ncbi.nlm.nih.gov/pubmed/37148345 http://dx.doi.org/10.1007/s10529-023-03380-0 |
Ejemplares similares
-
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
por: Naik, Biswajit, et al.
Publicado: (2020) -
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19
por: Ojha, Rupal, et al.
Publicado: (2020) -
Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics
por: Panda, Mamta, et al.
Publicado: (2022) -
Translational vaccinomics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus
por: Singh, Satyendra, et al.
Publicado: (2023) -
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
por: Panda, Mamta, et al.
Publicado: (2022)